Anti-cancer activity of Ruellia squarrosa against human prostate cancer cell line
Ruellia species are traditionally used for the treatment of flu, fever and inflammation. The aim of this study was to evaluate the anticancer activity of Ruellia squarrosa extracts against human prostate cancer (PC3) cell line. Dichloromethane and methanol extracts of aerial and root parts of the plant were made by maceration. Anticancer activity was estimated by MTT assay and percentage inhibition of cells was calculated. Results of MTT showed that 30 mg/ml of dichloromethane extract of root parts of the plant showed moderate anticancer activity (58% inhibition) against PC3 cell line with IC50 15.4 ± 0.3. It was concluded that R. squarrosa (root) possesses anticancer activity against human prostate cancer (PC3) cell line.
Alesiani D, Canini A, DAbrosca B, DellaGreca M, Fiorentino A, Mastellone C, Pacifico S. Antioxidant and antiproliferative activities of phytochemicals from Quince Cydonia vulgaris peels. Food Chem. 2010; 118: 199-207.
Channabasava, Govindappa M. First report of anticancer agent, lapachol producing endophyte, Aspergillus niger of Tabebuia argentea and its in vitro cytotoxicity assays. Bangladesh J Pharmacol. 2014; 9: 129-39.
Chen FA, Shieh P, Kuo D, Hsieh C. Evaluation of the anti-oxidant activity of Ruellia tuberosa. Food Chem. 2006; 94: 14-15.
Kandaswami C, Lee LT, Lee PP, Hwang JJ, Ke FC, Huang YT, Lee MT. The antitumor activities of flavonoids. In Vivo. 2005; 19: 895-909.
Lin C, Huang Y, Cheng L, Sheu S, Chen C. Bioactive flavonoid from Ruellia tuberosa. J China Med. 2006; 17: 103-09.
Kaur M, Kalia AN. Convolvulus arvensis: A useful weed. Int J Pharm Pharm Sci. 2012; 4: 38-40
Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics. CA Cancer J Clin. 2005, 55; 74-108.
Qadir MI, Ali M, Ibrahim Z. Anticancer activity of Morus nigra leaves extract. Bangladesh J Pharmacol. 2014; 9: 496-97.
Copyright (c) 2015 Muhammad Khurram Afzal, Muhammad Uzair, Bashir Ahmad Chaudhry
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).